TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,000 | -64.3% | 390 | -61.3% | 0.00% | -60.0% |
| Q2 2022 | $14,000 | 0.0% | 1,009 | 0.0% | 0.01% | +11.1% |
| Q1 2022 | $14,000 | 0.0% | 1,009 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $14,000 | -39.1% | 1,009 | -27.5% | 0.01% | -43.8% |
| Q3 2021 | $23,000 | +35.3% | 1,392 | +38.9% | 0.02% | +33.3% |
| Q2 2021 | $17,000 | +6.2% | 1,002 | +11.1% | 0.01% | -7.7% |
| Q1 2021 | $16,000 | +6.7% | 902 | +8.8% | 0.01% | 0.0% |
| Q4 2020 | $15,000 | – | 829 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |